The three-year award from the National Institute for Health and Care Research will support finalization of the test as well as initial validation studies.

The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.

Last week, readers were most interested in a story about the FDA's decision not to appeal a court decision vacating the agency's LDT rule.

The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

Multiple presentations at the meeting discussed the utility of circulating tumor DNA to guide treatment for colorectal cancer.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.

Called Velo, the system can perform true PCR testing in 10 minutes or less and is intended for use in decentralized spaces.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

The recommendations, contained in a report to Congress, follow the GAO's inclusion of the HHS on its High-Risk List of government operations due to "persistent deficiencies in [its] ability to perform ...